PROVIDERS

NanoBone is a bone graft substitute consisting of nanocrystals of hydroxyapatite (HA) bioidentical to human bone, dispersed in an amorphous silica gel matrix (ASG).

NanoBone Technology

Bioidentical to human bone
Forms a composite with ASG
NanoBone HA has 40x surface area of other HA-based bone grafts

ASG

Initiates Clotting Factor XII
Triggers angiogenesis and new bone formation
Rapidly replaced by an autologous organic matrix

Autologous organic matrix initiates cell-mediated bone formation and resorption

Technology Monograph

please hover over any slide to pause slideshow

"I have complete confidence in arthrodesis achieved in a timely fashion with NanoBone with no threat of overgrowth or reactive airway marrow soft tissue associated with the biologics.”

Michael Schneier, MD,

Neurosurgical Consulting,

Las Vegas, NV

FEATURED CASE STUDIES

Elderly Cervical Fusion - Udani

Multilevel cervical disc disease treated with posterior instrumentation and posterolateral application of nanocrystalline hydroxyapatite

View Now

Open Tibial Fracture - Ortega

Application of nanocrystalline hydroxyapatite
in an open tibial fracture with bony defect

View Now

Tibial Shaft Fracture in Alcoholic - Shulz

Repair of an infected tibial shaft fracture in a 60- year-old alcoholic using nanocrystalline hydroxyapatite

View Now

Case Study Archives

FEATURED CLINICAL ABSTRACT SUMMARIES

Kienast, B. et al. Nanostructured synthetic bone substitute material for treatment of bone defects. Results of an observational study, Trauma and Occupational Health. 2016; 18(4):308-318.

View Now

Abedi, A. et al., Examination of the Role of Cells in Commercially Available Cellular Allografts in Spine Fusion. An in Vivo Animal Study, The Journal of Bone and Joint Surgery. 2020; 102(24):p e135.

View Now

WEBINARS